Fortress Biotech Reports Record Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Highlights

    NEXT STORY
    ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2019
    PREV STORY
    GENESIS HEALTHCARE REPORTS SOLID FOURTH QUARTER AND YEAR END 2019 RESULTS
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cempra Presents Data on Ophthalmic Solithromycin at ARVO

    CHAPEL HILL, N.C., May 10, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    Helsinn Group announces agreement to acquire worldwide rights to Valchlor/Ledaga, an approved and marketed alkylating agent for topical treatment of mycosis fungoides type cutaneous T-cell lymphoma

    Helsinn Group announces agreement to acquire worldwide rights to Valchlor®/Ledaga® - an approved and marketed ...

    author_avatar
    NASDAQ Market News

    Beroni Group Receives First Commercial Order for its COVID-19 Test Kits from Japan

    author_avatar
    NASDAQ Market News